Download CCG & Trust Reports

for access to your CCG's reports

Current planned work programme  

(The programme is subject to revisions from the Keele Oversight Group and may be altered according to the availability of specialist contributors.)

May 2017:

  • Class review of newer oral anticoagulants (NOACs) for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation


July 2017:

  • Pitolisant for the treatment of narcolepsy
  • Guanfacine for the treatment of ADHD


September 2017:

  • Class review of fixed-dose combination products in type 2 diabetes